We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$640M
AUM Growth
+$42M
Cap. Flow
+$22.9M
Cap. Flow %
3.57%
Top 10 Hldgs %
39.6%
Holding
108
New
27
Increased
17
Reduced
24
Closed
21

Top Buys

Rank Stock Value
1
PRAX icon
Praxis Precision Medicines
PRAX
+$8.95M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$7.93M
3
SHLT
SHL Telemedicine Ltd American Depositary Shares
SHLT
+$7.92M
4
NVMI
Nova
NVMI
+$7.16M
5
TSEM icon
Tower Semiconductor
TSEM
+$6.92M

Top Sells

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$10.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$8.87M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$8.02M
4
LLY icon
Eli Lilly
LLY
+$6.71M
5
MSFT icon
Microsoft
MSFT
+$6.37M

Sector Composition

Rank Sector Weight
1 Healthcare 57.28%
2 Technology 9.65%
3 Consumer Discretionary 2.53%
4 Utilities 0.59%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGEN icon
76
Compugen
CGEN
$222M
$1.4M 0.22%
+1,229,808
New +$1.07M
MRSN
77
DELISTED
Mersana Therapeutics
MRSN
$1.38M 0.22%
16,742
+16,317
+3,839% +$2.39M
ELEV
78
DELISTED
Elevation Oncology
ELEV
$1.37M 0.21%
+900,000
New +$2.37M
DYN icon
79
Dyne Therapeutics
DYN
$4.7B
$1.35M 0.21%
119,918
-99,398
-45% -$1.17M
INBX
80
DELISTED
Inhibrx, Inc. Common Stock
INBX
$1.3M 0.2%
+50,000
New +$1.17M
MDWD icon
81
MediWound
MDWD
$181M
$1.18M 0.19%
111,127
– –
PMVP icon
82
PMV Pharmaceuticals
PMVP
$59.2M
$1.18M 0.18%
187,800
– –
IMTXW
83
DELISTED
Immatics N.V. Warrants
IMTXW
$342K 0.05%
100,000
– –
INFI
84
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$311K 0.05%
1,476,000
– –
BGMS
85
Bio Green Med Solution Inc
BGMS
$4.91M
$147K 0.02%
69
– –
ARBE icon
86
Arbe Robotics
ARBE
$80.3M
$125K 0.02%
43,165
– –
AMGN icon
87
Amgen
AMGN
$208B
– –
-10,000
Closed -$2.42M
ANNX icon
88
Annexon
ANNX
$835M
– –
-250,000
Closed -$963K
CRNX icon
89
Crinetics Pharmaceuticals
CRNX
$8.84B
– –
-82,747
Closed -$1.33M
IWM icon
90
PUT
iShares Russell 2000 ETF
IWM
$79.8B
– –
-420,900
Closed -$75.1M
KNSA icon
91
Kiniksa Pharmaceuticals
KNSA
$5.8B
– –
-450,283
Closed -$4.85M
KROS icon
92
Keros Therapeutics
KROS
$199M
– –
-30,119
Closed -$1.29M
MIRM icon
93
Mirum Pharmaceuticals
MIRM
$6.46B
– –
-109,336
Closed -$2.63M
NTR icon
94
Nutrien
NTR
$33.2B
– –
-145,466
Closed -$10.7M
PCVX icon
95
Vaxcyte
PCVX
$7.81B
– –
-90,000
Closed -$3.37M
PERI icon
96
Perion Network
PERI
$375M
– –
-130,000
Closed -$5.15M
QQQ icon
97
Invesco QQQ Trust
QQQ
$453B
– –
-26,353
Closed -$8.87M
QURE icon
98
CALL
uniQure
QURE
$3.03B
– –
-175,400
Closed -$3.53M
SPY icon
99
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
– –
-75,000
Closed -$30.7M
SYRE icon
100
Spyre Therapeutics
SYRE
$8.54B
– –
-25,859
Closed -$187K
1 2 3
4
5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2023 Portfolio in Review

As of Q2 2023, Sphera Funds Management held 108 positions worth $640M, up 7% from $598M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sphera Funds Management deployed $22.9M of net new capital in Q2 2023, opening 27 new positions and adding to 17 existing holdings. Its largest new stake was Praxis Precision Medicines: 584,289 shares worth $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $8.02M trimmed.

  • Sphera Funds Management's largest Q2 2023 buy was Praxis Precision Medicines: 584,289 shares worth $10.1M.
  • Sphera Funds Management added most to Amazon in Q2 2023, an estimated $4.41M increase.
  • Sphera Funds Management's biggest Q2 2023 reduction was Teva Pharmaceuticals, cutting an estimated $8.02M.
  • Sphera Funds Management fully exited Nutrien in Q2 2023, selling an estimated $10.7M.
  • Sphera Funds Management's ten largest holdings make up 40% of its $640M portfolio in Q2 2023.
  • Sphera Funds Management opened 27 new positions and closed 21 in Q2 2023.
  • Sphera Funds Management's portfolio value rose 7% quarter-over-quarter to $640M.

Based on Sphera Funds Management's 13F filing for Q2 2023, filed 14 Aug 2023.